2017;18:779 –91. 25. Pujade-Lauraine E, Hilpert F, Weber B, Reuss A, Poveda A, Kristensen G, et al. Bevacizumab combined with chemotherapyfor platinum-resistant recurrent ovarian cancer: The AURELIAopen-label randomized phase III trial. J Clin Oncol. 2014;32:1302 –8.Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer 26. Pujade-Laurainea E, Fujiwarab K, Ledermannc JA, Ozad AM, Kristeleitc RS, Ray-Coquarde IL, et al. Avelumab alone or in combination with pegylated liposomal doxorubicin versus pegy- lated liposomal doxorubicin alone in platinum-resistant orrefractory epithelial ovarian cancer: Primary and biomarker ana- lysis of the phase III JAVELIN Ovarian 200 trial. 50th Annual Meeting of the Society of Gynecologic Oncology; March 16 –19; Honolulu, HI; 2019.